Evidence map›Paper›PMID 36770914›Full record

ArticleMolecules (Basel, Switzerland)2023

Rare Missense Variants of the Human β4 Subunit Alter Nicotinic α3β4 Receptor Plasma Membrane Localisation.

Sara Francesca Colombo, Cecilia Galli, Arianna Crespi, Massimiliano Renzi, Cecilia Gotti

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. The Role of Nicotinic Receptors on CaCurrent issues in molecular biology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sara Francesca ColomboCNR Institute of Neuroscience, 20854 Vedano al Lambro, Italy.ORCID 0000-0001-9714-3961
Cecilia GalliCNR Institute of Neuroscience, 20854 Vedano al Lambro, Italy.
Arianna CrespiCNR Institute of Neuroscience, 20854 Vedano al Lambro, Italy.
Massimiliano RenziDepartment of Physiology and Pharmacology, "Sapienza" University of Rome, 00185 Rome, Italy.ORCID 0000-0001-6973-3569
Cecilia GottiCNR Institute of Neuroscience, 20854 Vedano al Lambro, Italy.ORCID 0000-0001-5358-8643

Funding

Fondazione Monzino, Milano, Italy 2016
6 · The paper itself

Abstract

α3β4 nicotinic acetylcholine receptors (nARs) are pentameric ligand-gated cation channels that function in peripheral tissue and in the peripheral and central nervous systems, where they are critical mediators of ganglionic synaptic transmission and modulators of reward-related behaviours. In the pentamer, two α3β4 subunit couples provide ligand-binding sites, and the fifth single (accessory) subunit (α3 or β4) regulates receptor trafficking from the endoplasmic reticulum to the cell surface. A number of rare missense variants of the human β4 subunit have recently been linked to nicotine dependence and/or sporadic amyotrophic lateral sclerosis, and altered responses to nicotine have been reported for these variants; however, it is unknown whether the effects of mutations depend on the subunit within the ligand-binding couples and/or on the fifth subunit. Here, by expressing single populations of pentameric receptors with fixed stoichiometry in cultured cells, we investigated the effect of β4 variants in the fifth position on the assembly and surface exposure of α3β4 nAChRs. The results demonstrate that the missense mutations in the accessory subunit alone, despite not affecting the assembly of α3β4 receptors, alter their trafficking and surface localisation. Thus, altered trafficking of an otherwise functional nAChR may underlie the pathogenic effects of these mutations.

Indexed as

Mutation, MissenseReceptors, NicotinicCell MembraneHumansLigandsNicotineLigandsNicotineReceptors, NicotinicnAChRsSNPsstoichiometryα3β4 nicotinic subtypeα3β4 trafficking

Identifiers

PMID36770914
PMCPMC9919425

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.